Research & Drug News for Fibromyalgia and Chronic Fatigue Syndrome
Get results of the first year-long studies of Cymbalta (duloxetine) as a fibromyalgia treatment.
See what researchers have uncovered about an apparent hormonal trigger of fibromyalgia in women.
See what a study shows about the effects of acupuncture on people with fibromyalgia and what researcher recommend for treatment.
A synthetic version of norepinephrine moves forward.
Two independent studies show extra hardship faced by smokers with fibromyalgia.
See how lowering caloric intake helps some people preserve and even improve memory.
See why some researchers think problems linked to low cortisol should be treated by lowering cortisol levels even farther.
A group of researchers say they've discovered the key to an objective test for chronic fatigue syndrome that lies in the mitochondria.
Find out why researchers recommend CoQ10 supplements for people with fibromyalgia.
Is it too simple to be true? Find out what research shows about sunlight and fibromyalgia.
And then there were three! Learn more about the third drug to be FDA approved as a fibromyalgia treatment.
HHV-6 has long been suspected as a possible trigger for chronic fatigue syndrome. See what researchers have discovered about how it's transmitted genetically.
Drugs including on this quarterly list include one for fibromyalgia, diabetes, arthritis and more.
See why researchers say a sleep study could become a diagnostic test for fibromyalgia.
Another region of the brain and several new substances are now considered possible causes for the symptoms of fibromyalgia.
Get the latest research news on a drug currently before the FDA as a potential fibromyalgia treatment.
Get the latest information on the safety and efficacy of fibromyalgia-treatment Lyrica (pregabalin).
The experimental anti-viral drug Ampligen (poly I: poly C12U) has cleared an important hurdle with the FDA, which could pave the way for it to become the first treatment ever approved for chronic fatigue syndrome (CFS or ME/CFS).
New research points to an ancient retrovirus as a possible partial cause of chronic fatigue syndrome (CFS or ME/CFS) and multiple sclerosis (MS).
We have yet another viral discovery linked to chronic fatigue syndrome (CFS or ME/CFS) - and it's a protein in a particular strain of human herpesvirus-6 (HHV-6), a virus long suspected of playing a role in many cases of ME/CFS.
After reporting a few months ago that it may force makers of 11 anti-seizure drugs, including the fibromyalgia treatments Lyrica (pregabalin) and Neurontin (gabapentin), to carry a prominent suicide-risk label, an FDA panel now says the risk doesn't appear great enough for that type of labeling.
Cymbalta (duloxetine) has become the second drug to be FDA approved for treating fibromyalgia.
Effirma (oral flupirtine) is now going through the early stages of seeking FDA approval for treating fibromyalgia. Unlike many fibromyalgia drugs, Effirma is not addictive and does not have significant side effects.
Learn more about Ampligen, which could become the first drug ever approved for chronic fatigue syndrome. This British research document contains a wealth of information on Ampligen, which is an antiviral drug that's given intravenously.
Research further links fibromyalgia to central nervous system abnormalities.
New study examines hippocampus dysfunction in people with fibromyalgia.
The CDC is hoping to learn more about hormonal imbalances and immune issues connected to chronic fatigue syndrome.
Multiple studies appear to confirm the effectiveness of cortisol treatment for fibromyalgia and chronic fatigue syndrome. But is cortisol replacement safe for treating fibromyalgia?
Find out what symptoms go with which chronic fatigue syndrome subtypes, and why subtyping is important to both researchers and people with chronic fatigue syndrome.
A decisionon whether milnacipran, which boosts the neurotransmitters norepinephrine and serotonin, could be made by the end of October, giving people with fibromyalgia another option for drug therapy.
Several chronic fatigue syndrome studies and projects are underway in early 2008, led by leading CFS expert Dr. Nancy Klimas. Get a look at what's going on know as well as what to expect for the future of chronic fatigue syndrome research.
Women get fibromyalgia and chronic fatigue syndrome at far higher rates than men. Find out what factors researchers believe could be behind women's greater susceptibility to fibromyalgia and chronic fatigue syndrome.
This article looks at evidence that people with fibromyalgia have abnormalities in the central nervous system that may contribute to their symptoms.
Review of studies looks into injecting bee venom into acupuncture points help relieve muscloskeletal pain.
Study supports the theory that people with fibromyalgia are sensitive to much more than pain.
British study examines effects of cognitive-behavioral therapy combined with medication as a treatment for chronic fatigue syndrome. Note: Cognitive-behavioral therapy is a common CFS treatment in UK but is highly controversial in the U.S.
Study examined whether pain processing in fibromyalgia could be detected with a brain scan.
Learn about four possible causes of chronic fatigue syndrome that researchers are exploring.
This article abstract discusses evidence showing that the brains of people with fibromyalgia function differently from the brains of other people.
Find out how common it is for people with chronic fatigue syndrome (CFS or ME/CFS) to have developed the condition after contracting a human parvovirus infection.
Eli Lily, the company that makes Cymbalta (duloxetine) says a large study shows the selective serotonin norephinephrine reuptake inhibitor is effective at fighting the pain of fibromyalgia. A New Drug Application already is before the FDA.
Patients with fibromyalgia treated with a synthetic form of marijuana, nabilone, showed significant reductions in pain and anxiety in a first-of-its-kind study, published in The Journal of Pain.
See what researchers found when comparing perceived disability levels and mental health of people with fibromyalgia to those of people with other pain conditions.
Evidence in support of intracellular immune dysfunctions in people with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is accumulating, but few studies have addressed intracellular immunity as a potential therapeutic target.